Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms;Applicazioni cliniche del linfonodo sentinella nella stadiazione e nel trattamento dei tumori solidi

Minerva Chirurgica

Volumn 60, Issue 4, 2005, Pages 217-233

  Gipponi, M ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Neoplasms, diagnosis; Neoplasms, pathology; Sentinel lymph node biopsy

Indexed keywords

ALPHA2B INTERFERON; INDOCYANINE GREEN; TRACER;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HISTOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHATIC DRAINAGE; MELANOMA; MERKEL CELL TUMOR; METASTASIS; PENIS CANCER; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SOLID TUMOR; URINARY TRACT CANCER; UTERINE CERVIX CANCER; VULVA TUMOR;

BREAST NEOPLASMS; FEMALE; GASTROINTESTINAL NEOPLASMS; GENITAL NEOPLASMS, FEMALE; HUMANS; MELANOMA; NEOPLASM STAGING; NEOPLASMS; SENTINEL LYMPH NODE BIOPSY;

EID: 27144447715     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
2. Karakousis CP, Velez AF, Spellman JE, Scarozza J. The technique of sentinel node biopsy. Eur J Surg Oncol 1996;22:271-5.
3. Albertini JJ, Cruse CW, Rapaport D, Wells K, Ross M, DeConti R et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996;223:217-24.
4. Leong SP, Steinmetz I, Habib FA, McMillan A, Gans JZ, Allen RE Jr et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 1997;132:666-73.
5. Bostick P, Essner R, Glass E, Kelley M, Sarantou T, Foshag LJ et al. Comparison of blue dye and probe assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basin. Arch Surg 1999;134:43-9.
6. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;222:394-401.
7. th ed. New York: Springer; 2002.
8. WHO declares lymphatic mapping to be the standard of care for melanoma. Oncology 1999;13:288.
9. Starz H, Bernd-Rudiger B, Kramer KU, Buchels H, Wang HJ. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001;91:2110-20.
10. Veronesi U, Adamus J, Bandiera DC, Brennhovd O, Caceres E, Cascinelli N et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 1982;49:2420-30.
11. Sim FH, Taylor WF, Ivins JC, Pritchard DJ, Soule EH. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Cancer 1978;41:948-56.
12. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial - WHO Programme. Lancet 1998;351:793-6.
13. Balch CM, Soong S-J, Bartolucci AA, Urist MM, Karakousis CP, Smith TJ et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996;224:255-66.
14. Balch CM, Soong S-J, Ross MI, Urist MM, Karakousis CP, Temple WJ et al. Long-term results of a multi-institutional randomized clinical trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1 to 4 mm): Intergroup Melanoma Surgical Trial. Ann Surg Oncol 2000;7:87-97.
15. Ross MI. Surgical management of stage I and II melanoma patients: approach to the regional lymph node basin. Semin Surg Oncol 1996;12:394-401.
16. Ferrone CR, Panageas KS, Busam K, Brady MS, Coit DG. Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status. Ann Surg Oncol 2002;9:637-45.
17. Burke HB, Hutter RVP, Henson DE. Breast Carcinoma. In: Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP, Sobin LH, editors. Prognostic factors in Cancer. Berlin: Springer; 1995.p.165-76.
18. Canavese G, Catturich A, Vecchio C, Tomei D, Gipponi M, Bruzzi P et al. Prognostic role of lymph node level involvement in patients undergoing axillary dissection for breast cancer. Eur J Surg Oncol 1998;24:104-9.
19. Hladiuk M, Huchcroft S, Temple W, Schnurr BE. Arm function after axillary dissection for breast cancer: a pilot study to provide parameters estimates. J Surg Oncol 1992;50:47-52.
20. Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT. Assessment of morbidity from complete axillary dissection. Br J Cancer 1992;66:136-8.
21. Maunsell E, Brisson J, Deshenes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg 1993;36:315-20.
22. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer: a review. Cancer 1995;76:1491-512.
23. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992;339:1-15, 71-85.
24. Goldhirsch A, Wood WC, Senn HJ, Glick JH, Gelber RD. Meeting highlights: International Consensus Panel on the treatment of primary breast cancer. J Natl Cancer Inst 1995;87:144l-5.
25. th Annual Meeting. Alexandria (VA): American Society of Clinical Oncology; 1998.p. 132-41.
26. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312:674-81.
27. Orr R. The impact of prophylactic axillary node dissection on breast cancer survival. A Bayesian meta-analysis. Ann Surg Oncol 1999;6:109-16.
28. Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C et al. Sentinel lymph node biopsy as a new marker for therapeutic planning in breast cancer patients. J Surg Oncol 2004;85:102-11.
29. Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000;18:2553-9.
30. Veronesi U, Paganelli G, Viale G, Luini A, Zurridda S, Galimberti V et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-53.
31. FONCAM. I Tumori della Mammella. Linee guida sulla diagnosi, il trattamento e la riabilitazione. Milano: Scientific Press; 2003.
32. Gentilini O, Cremonesi M, Trifirò G, Ferrari M, Baio SM, Caracciolo M et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004; 15:1348-51.
33. rd et al. The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancer. J Am Coll Surg 2003;197:529-35.
34. Kumar R, Jana S, Heiba SI, Dakhel M, Axelrod D, Siegel B et al. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable or non-palpable breast cancer. J Nucl Med 2003;44:7-10.
35. Port ER, Fey J, Gemignani ML, Heerdt AS, Montgomery LL, Petrek JA et al. Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma. J Am Coll Surg 2002;195:167-72.
36. Bedrosian I, Reynolds C, Mick R, Callans LS, Grant CS, Donohue JH et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 2000;88:2540-5.
37. Chung MH, Ye W, Giuliano AE. Role of sentinel lymph node dissection in the management of large (>5 cm) invasive breast cancer. Ann Surg Oncol 2001;8:688-92.
38. Haigh P, Hansen NM, Karen Q, Giuliano AE. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 2000;7:21-7.
39. Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Carlson DJ et al. The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol 2002;9:272-7.
40. Klauber-DeMore N, Tan LK, Liberman L, Kaptain S, Fey J, Borgen P et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma in situ and ductal carcinoma in situ with microinvasion? Ann Surg Oncol 2000;7:636-42.
41. Cox CE, Nguyen K, Gray RJ, Salud C, Ku NN, Dupont E et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 2001;67:513-21.
42. McMaster KM, Cho C, Wong SL, Martin RCG, Edwards MJ. Sentinel lymph node biopsy in patients with ductal carcinoma in situ. A proposal. Cancer 2002;95: 15-20.
43. Kelly TA, Kim JA, Patrick R, Grundfest S, Crowe JP. Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ. Am J Surg 2003;186:368-70.
44. Morgan MK, Minuta JJ. Surgical management of vulvar cancer. Semin Surg Oncol 1999;17:168-72.
45. Iversen T, Aalders JG, Christiensen A, Kolstad P. Squamous cell carcinoma of the vulva: a review of 424 patients, 1956-74. Gynecol Oncol 1980;9:271-9.
46. Sutton GP, Miser MR, Stehman FB, Look KY, Ehrlich CE. Trends in the operative management of invasive squamous carcinoma of the vulva at Indiana University. 1974-88. Am J Obstet Gynecol 1991;164:1472-81.
47. Makar APH, Scheistroen M, Van Den Weyngaert D, Trope CG. Surgical management of stage I and II vulvar cancer: the role of the sentinel node biopsy. Review of literature. Int J Gynecol Cancer 2001;11:255-62.
48. Moore RG, DePasquale SE, Steinhoff MM, Gajewski W, Steller M, Noto R et al. Sentinel node identification and the ability to detect metastatic tumor to inguinal lymph nodes in squamous cell cancer of the vulva. Gynecol Oncol 2003;89:475-9.
49. De Hullu JA, Hollemo H, Piers DA, Verheijen RH, van Diest PJ, Mounts MJ et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 2000;18:2811-6.
50. Hatch KD. Cervical cancer. In: Berek GS, Hacker NF, editors. Practical Gynecologic Oncology. Baltimore: Williams & Wilkins; 1994.p.243-83.
51. Plentl A, Friedman EA. Lymphatic system of the female genitalia. In: Plentl A, Friedman EA, editors. Lymphatics of the cervix uteri. Philadelphia: WB Saunders; 1971. Vol. 2, p.75-84.
52. Verheijen RHM, Pijpers R, van Diest PJ, Burger CW, Buist MR, Kenemans P. Sentinel node detection in cervical cancer. Obstet Gynecol 2000;96:135-8.
53. Levenback C, Coleman RL, Burke TW, Lin WM, Erdman W, Deavers M et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol 2002;20:688-93.
54. Dargent D, Enria R. Laparoscopic assessment of the sentinel node in early cervical cancer. Technique, preliminary results and future developments. Crit Rev Oncol Hematol 2003;48:305-10.
55. Marchiole P, Buenerd A, Scoazec JY, Dargent D, Mathavet P. Sentinel lymph node biopsy is not accurate in predicting lymph node status for patients with cervical carcinoma. Cancer 2004;100:2154-9.
56. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD et al. Relationship between surgical-pathologic risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991;40:55-65.
57. 99mTc colloid and blue dye in patients with endometrial cancer. Tumori 2002;88:S9-10.
58. Cabanas RM. An approach for the treatment of penile cancer. Cancer 1977;39:456-61.
59. Horenblas S, Jansen L, Meinhardt W, Hoefnagel CA, de Jong D, Nieweg OE. Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure. J Urol 2000;163:100-4.
60. Tanis PJ, Lont AP, Meinhardt W, Olmos RA, Nieweg OE, Horenblas S. Dynamic sentinel node biopsy for penile cancer: reliability of a staging technique. J Urol 2002;168:76-80.
61. Lont AP, Horenblas S, Tanis PJ, Gallee MP, van Tinteren H, Nieweg OE. Management of clinically node negative penile carcinoma: improved survival after the introduction of dynamic sentinel node biopsy. J Urol 2003;170:783-6.
62. Kroon BK, Horenblas S, Estourgie SH, Lont AP, Valdes Olmos RA, Nieweg OE. How to avoid false negative dynamic sentinel node procedures in penile carcinoma. J Urol 2004;171:2191-4.
63. Wawroschek F, Vogt H, Weckermann D, Wagner T, Harzmann R. The sentinel lymph node concept in prostate cancer. First results of gamma probe-guided sentinel lymph node identification. Eur Urol 1999;36: 595-600.
64. Wawroschek F, Vogt H, Weckermann D, Wagner T, Hamm M, Harzmann R. Radioisotope guided pelvic lymph node dissection for prostate cancer. J Urol 2001; 166:1715-9.
65. Rudoni M, Sacchetti GM, Leva L, Inglese E, Monesi G, Minocci D et al. Recent applications of the sentinel lymph node concept: preliminary experience in prostate cancer. Tumori 2002;88:S16-7.
66. Sherif A, De La Torre M, Malmstrom PU, Thorn M. Lymphatic mapping and detection of sentinel nodes in patients with bladder cancer. J Urol 2001;166:812-5.
67. st International Congress on Sentinel Node in Diagnosis and Treatment of Cancer. Amsterdam, 1999.
68. Ross GL, Shoaib T, Soutar DS, MacDonald DG, Camilleri IG, Bessent RG et al. The First International Conference on Sentinel Node Biopsy in Mucosal Head and Neck Cancer and adoption of a multicenter trial protocol. Ann Surg Oncol 2002;9:406-10.
69. Lim RB, Wong JH. Sentinel lymphadenectomy in gynaecologic and solid malignancies other than melanoma and breast cancer. Surg Clin North Am 2000;80:1777-98.
70. Wiseman SM, Hicks WL, Chu QD, Rigual NR. Sentinel lymph node biopsy in staging of differentiated thyroid cancer: a critical review. Surg Oncol 2002;11:137-42.
71. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-28.
72. Little AG, DeHoyos A Kirgan DM, Arcomano TR, Murray KD. Intraoperative lymphatic mapping for non-small cell lung cancer: the sentinel node technique. J Thorac Cardiovasc Surg 1999;117:220-4.
73. Sugi K, Fukuda M, Nakamura H, Kaneda Y. Comparison of three tracers for detecting sentinel lymph nodes in patients with clinical NO lung cancer. Lung Cancer 2003;39:37-40.
74. Schmidt FE, Woltering EA, Webb WR, Garcia OM, Cohen JE, Rozars MH. Sentinel nodal assessment in patients with carcinoma of the lung. Ann Thorac Surg 2002;74:870-4.
75. Liptay MJ, Grodin SC, Fry WA, Pozdol C, Carson D, Knop C et al. Intraoperative sentinel lymph node mapping in non-small-cell lung cancer improves detection of micrometastases. J Clin Oncol 2002;20:1984-8
76. Melfi FM, Chella A, Monconi GF, Givigliano F, Boni G, Mariani G et al. Intraoperative radioguided sentinel lymph node biopsy in non-small-cell lung cancer. Eur J Cardiothorac Surg 2003;23:214-20.
77. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H. Can sentinel node biopsy indicate rational extent of lymphadenectomy in gastric cancer surgery? Langenbecks Arch Surg 1999;384:149-57.
78. Siewert JR, Sendler A. Potential and futility of sentinel node detection for gastric cancer. Recent Results Cancer Res 2000;157:259-69.
79. Sano T, Katai H, Sasako M, Maruyama K. Gastric lymphadenectomy and detection of sentinel nodes. Recent Results Cancer Res 2000;157:253-8.
80. Kitagawa Y, Fujii H, Mukai M, Kubota T, Ando N, Watanabe M et al. The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am 2000;80: 1799-809.
81. Ichikura T, Morita D, Uchida T, Okura E, Majima T, Ogawa T et al. Sentinel node concept in gastric carcinoma. World J Surg 2002;26:318-22.
82. Sawai S, Takahashi S, Kato G et al. Endoscopic injection of activated carbon particles (CH44) for extending radical lymphadenectomy of gastric cancer. Jpn J Gastroenterol Surg 1985;18:912-7.
83. Catarci M, Guadagni S, Zacara F, Pistoia MA, Mastracchio A, Trecca A et al. Prospective randomized evaluation of preoperative endoscopic vital staining using CH40 for lymph node dissection in gastric cancer. Ann Surg Oncol 1998;5:580-4.
84. Hiratsuka M, Miyashiro I, Ishikawa O, Furukawa H, Motomura K, Ohigashi H et al. Application of sentinel node biopsy to gastric cancer surgery. Surgery 2001;129: 335-40.
85. Kitagawa Y, Ohgami M, Fujii H, Mukai M, Kubota T, Ando N et al. Laparoscopic detection of sentinel lymph nodes in gastrointestinal cancer: application for the novel minimally invasive surgery. Ann Surg Oncol 2001;8 (9 Suppl):86S-89S.
86. Joosten JJ, Strobbe LJ, Wauters CA, Pruszczynski M, Wobbes T, Ruers TJ. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 1999;86:482-6.
87. Bertagnolli M, Miedema B, Redston M, Dowell J, Niedzwiecki D, Fleshman J et al. Sentinel node staging of resectable colon cancer: results of a multicenter study. Ann Surg 2004;240:624-8.
88. Saha S, Dean N, Wong J, Weise D. Sentinel lymph node mapping in colorectal cancer. A review. Surg Clin North Am 2000;80:1811-9.
89. Saha S, Dan AG, Beutler T, Wiese D, Schochet E, Badin J et al. Sentinel lymph node mapping technique in colon cancer. Semin Oncol 2004;31:374-81.
90. Braat AE, Oosterhuis JW, Moll FC, de Vries JE. Successful sentinel node identification in colon carcinoma using Patent Blue V. Eur J Surg Oncol 2004;30:633-7.
91. Patten LC, Berger DH, Rodriguez-Bigas M, Mansfield P, Delpassand E, Cleary KR et al. A prospective evaluation of radiocolloid and immunohistochemical staining in colon carcinoma lymphatic mapping. Cancer 2004;100:2104-9.
92. Bertoglio S, Sandrucci S, Percivale P, Goss M, Gipponi M, Moresco L et al. Prognostic value of sentinel lymph node biopsy in the pathologic staging of colorectal cancer patients. J Surg Oncol 2004;85:166-70.
93. Shaw JHF, Rumball E, Merkel cell tumor, clinical behaviour and treatment. Br J Surg 1991;78:138-42.
94. Victor NS, Morton B, Smith JW. Merkel cell cancer: is prophylactic lymph node dissection indicated? Am Surg 1996;62:879-82.
95. Yengpruksawan A, Coit DG, Thaler HI, Urmacher C, Knapper WK. Merkel cell carcinoma prognosis and management. Arch Surg 1991;126:1514-9
96. Hitchcock CL, Bland KI, Laney RG, Franzini D, Harris B, Copeland E. Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment. Ann Surg 1988;207:201-7.
97. Hill AD, Brady MS, Coit DG. Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg 1999;85:518-21.
98. Messina JL, Reintgen DS, Cruse CW, Rappaport DP, Berman C, Fenske NA et al. Selective lymphadenectomy in patients with Merkel cell carcinoma. Ann Surg Oncol 1997;4:389-95.
99. Mehrany K, Otley CC, Weenig RH, Phillips PK, Randall K, Nguyen TH. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel Cell Carcinoma. Dermatol Surg 2002;28:113-7.